← FDA DRUG APPROVALS

FDA ANDA · ANDA203371

GALBRIELA

norethindrone and ethinyl estradiol and ferrous fumarate

Sponsor: XIROMED

APPLICATION
ANDA203371
TYPE
ANDA
ORIGINAL APPROVAL
2014-04-23
LATEST ACTION
2014-04-23
ROUTE
ORAL
DOSAGE FORM
TABLET, CHEWABLE
MARKETING STATUS
Prescription

Products

NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATEPrescription
ETHINYL ESTRADIOL 0.025MG, NORETHINDRONE 0.8MG · TABLET, CHEWABLE · ORAL

Approval history

2014-04-23UNKNOWN · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →